Cite

HARVARD Citation

    McDaid, W. et al. (2019). Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. Nanoscale. 11 (42), pp. 20261-20273. [Online]. 
  
Back to record